Search form

Topics:

ubmslateCL-logo-ubm

CL Mobile Menu

HPV

HPV

Despite new screening guidelines, most obstetrician-gynecologists continue to perform annual pap tests, according to a recent survey of members of the American Congress of Obstetricians and Gynecologists (ACOG).

A 2-dose quadrivalent human papillomavirus (HPV) vaccine series in girls may be as immunogenic as a 3-dose series, but there may be a loss of noninferiority to some genotypes after 2 years.

Authors of a new study identified four strategies for cervical cancer screening that maximize benefits while reducing the potential for harm.

The FDA has changed the Pregnancy Category of magnesium sulfate from ‘A’ to ‘D,’ indicating that there is “positive evidence of human fetal risk” when the drug is used during pregnancy.

Key points for primary care physicians from a new study: HIV-positive women are vulnerable to invasive cervical cancer. This finding underscores the need for screening per guidelines and to follow-up on abnormal Pap smears.

The human papillomavirus is also easily transmitted to the anus in men who have sex with men.

The use of APTIMA human papillomavirus (AHPV) assay for the detection of high-risk human papillomavirus E6/E7 oncogenic messenger RNA is an effective triage method for colposcopy referral in women with atypical squamous cells of undetermined significance cytology (ASC-US).

Pages

Subscribe to HPV on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.